RND - ETF AI Analysis
Top Page
First Trust Bloomberg R&D Leaders ETF (RND)
Rating:75Outperform
Price Target:―
Positive Factors
Leading Innovative Companies
The ETF’s largest positions include well-known technology and growth leaders that have generally shown strong performance, which can help drive returns.
Sector Diversification Within Growth Areas
Holdings spread across technology, consumer, health care, communication services, and industrials help reduce the impact if any one growth sector struggles.
Recent Short-Term Momentum
The fund has shown strong gains over the past month and modest gains over the last three months, suggesting improving short-term performance despite a slightly negative year-to-date result.
Negative Factors
High Concentration in a Few Stocks
A small group of large positions like Amazon, Alphabet, Nvidia, Microsoft, and Apple make up a big share of the portfolio, increasing the impact if any of these companies stumble.
Mixed Performance Among Top Holdings
Several major holdings, including Microsoft, Apple, Tesla, and Eli Lilly, have shown weak year-to-date performance, which has weighed on the fund’s overall results.
Limited Geographic Diversification
With almost all assets invested in U.S. companies, the ETF offers little exposure to international markets, which can increase vulnerability to U.S.-specific economic or policy risks.
RND vs. SPDR S&P 500 ETF (SPY)
AUM8.04M
RegionNorth America
Expense Ratio0.60%
Beta1.25
IssuerFirst Trust
Inception DateApr 30, 2024
Dividend YieldN/A
Asset ClassEquity
Index TrackedBloomberg R&D Leaders Select TR
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,493
30 Day Avg. Volume2,581
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
38.74Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RND Summary
The First Trust Bloomberg R&D Leaders ETF (RND) tracks the Bloomberg R&D Leaders Select index, focusing on companies that spend heavily on research and development. It mainly holds U.S. stocks and is tilted toward technology, consumer, and health care businesses. Well-known holdings include Amazon, Apple, Microsoft, and Nvidia. Someone might invest in this ETF to seek long-term growth by backing innovative companies that are constantly developing new products and services, while still getting diversification across several sectors. A key risk is that it’s heavily exposed to tech and growth stocks, so its price can rise and fall more sharply than the overall market.
How much will it cost me?The First Trust Bloomberg R&D Leaders ETF (RND) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on companies with strong research and development initiatives to drive innovation and growth.
What would affect this ETF?The First Trust Bloomberg R&D Leaders ETF (RND) could benefit from continued advancements in technology and healthcare, as these sectors make up a significant portion of its holdings and are often driven by innovation and R&D spending. However, rising interest rates or economic slowdowns could negatively impact growth-focused companies like those in the ETF, particularly in sectors such as consumer cyclical and technology. Regulatory changes in healthcare or technology could also pose risks to some of its top holdings.
RND Top 10 Holdings
RND is essentially an innovation-heavy, U.S.-focused bet on Big Tech and chipmakers, with names like Nvidia, Apple, Alphabet, and Amazon steering the ship. Nvidia and Broadcom have been rising on AI enthusiasm, helping power the fund, while Apple and Alphabet remain steady contributors despite some recent choppiness. On the flip side, Microsoft and Meta have been lagging, acting as a bit of a brake on returns. Tesla’s mixed performance adds volatility, while Eli Lilly and Amphenol quietly diversify the story beyond pure tech.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alphabet Class A | 8.62% | $694.08K | $4.34T | 110.50% | 85 Outperform | |
| Apple | 8.34% | $670.97K | $4.53T | 47.93% | 79 Outperform | |
| Amazon | 7.93% | $638.48K | $2.61T | 12.14% | 71 Outperform | |
| Nvidia | 7.59% | $611.09K | $4.71T | 22.22% | 76 Outperform | |
| Microsoft | 7.07% | $568.89K | $2.90T | -22.12% | 79 Outperform | |
| Eli Lilly & Co | 4.41% | $355.22K | $1.14T | 58.88% | 72 Outperform | |
| Broadcom | 4.09% | $329.03K | $1.71T | 36.42% | 76 Outperform | |
| Tesla | 3.83% | $308.11K | $1.48T | 40.95% | 73 Outperform | |
| Meta Platforms | 3.55% | $285.74K | $1.48T | -14.58% | 76 Outperform | |
| Amphenol | 3.30% | $265.90K | $202.48B | 62.83% | 78 Outperform |
RND Technical Analysis
Positive
―
Price Trends
31.57
Positive
30.20
Positive
30.16
Positive
Market Momentum
0.18
Negative
58.36
Neutral
88.95
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RND, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.55, equal to the 50-day MA of 31.57, and equal to the 200-day MA of 30.16, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 58.36 is Neutral, neither overbought nor oversold. The STOCH value of 88.95 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RND.
RND Peer Comparison
Comparison Results
Performance Comparison
RND
First Trust Bloomberg R&D Leaders ETF
32.23
5.07
18.67%
BAMD
Brookstone Dividend Stock ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
FDRS
Founder-Led ETF
―
―
―
YALL
God Bless America ETF
―
―
―
FFTY
Innovator IBD 50 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents